BofA Boosts Johnson & Johnson (JNJ) Price Target as Pipeline Outlook Improves [Yahoo! Finance]
Johnson & Johnson (JNJ)
Last johnson & johnson earnings: 4/14 06:31 am
Check Earnings Report
US:NYSE Investor Relations:
jnj.com
Company Research
Source: Yahoo! Finance
Johnson & Johnson (NYSE: JNJ ) is included among the 13 Best Defensive Dividend Stocks for 2025 BofA Boosts Johnson & Johnson (JNJ) Price Target as Pipeline Outlook Improves On March 3, BofA analyst Jason Gerberry raised the firm's price recommendation on Johnson & Johnson (NYSE:JNJ) to $253 from $227. It reiterated a Neutral rating on the shares. The firm said it updated its long-term revenue estimates to reflect new expectations for several pipeline assets nearing the market. Gerberry pointed in particular to Tecvayli and Inlexzo. He also noted that strong data from Tecvayli could have a knock-on effect on Darzalex by extending the duration of treatment. A few days later, on March 5, Reuters reported that Johnson & Johnson had launched a website that allows some patients in the US to purchase certain drugs directly. The platform is designed for people who do not have insurance or who pay for medications out of pocket. The website, called J&J Direct, currently lists three drug
Show less
Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JNJ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JNJ alerts
High impacting Johnson & Johnson news events
Weekly update
A roundup of the hottest topics
JNJ
News
- Dividend Aristocrats in a Shaky Market: KO, PG, JNJ, and 2 Others Built to Last [Yahoo! Finance]Yahoo! Finance
- Johnson & Johnson (JNJ) Declines More Than Market: Some Information for Investors [Yahoo! Finance]Yahoo! Finance
- Johnson & Johnson Announces U.S. FDA Approval of TECVAYLI® plus DARZALEX FASPRO® for Relapsed/Refractory Multiple Myeloma, Offering a Potential New Standard of Care as Early as Second Line [Yahoo! Finance]Yahoo! Finance
- Johnson & Johnson (JNJ) had its price target raised by JPMorgan Chase & Co. from $225.00 to $250.00. They now have a "neutral" rating on the stock.MarketBeat
- Johnson & Johnson Announces U.S. FDA Approval of TECVAYLI® plus DARZALEX FASPRO® for Relapsed/Refractory Multiple Myeloma, Offering a Potential New Standard of Care as Early as Second LinePR Newswire
JNJ
Earnings
- 1/21/26 - Beat
JNJ
Sec Filings
- 3/3/26 - Form 4
- 2/27/26 - Form 144
- 2/23/26 - Form 4
- JNJ's page on the SEC website